Brand Name: BRIUMVI
Generic Name: ublituximab
Primary Class: CD20-directed Antibody Interactions [MoA]
SPL Set ID: 3a77cd8c-811b-407c-9140-d0c5c26435c2 view on Dailymed | RXCUI: 2626353
Manufacturer Name: TG Therapeutics, Inc.
| Package NDC | Description |
|---|---|
| 73150-150-06 | 1 VIAL, SINGLE-DOSE in 1 CARTON (73150-150-06) / 6 mL in 1 VIAL, SINGLE-DOSE |